What the Brand Says About How These Medications May Work The brand's materials describe semaglutide as a medication that "may work through the GLP-1 pathway" and tirzepatide as one that "may work through both GIP and GLP-1 pathways." Per the official website, GLP-1-based treatment "may be considered as part of a broader provider-guided care plan for weight care," and the brand frames weight care generally as involving "a range of factors, including appetite signaling, metabolism, and overall health history" - not a single mechanism or a guaranteed outcome
doi: 10.1016/j.clindermatol.2017.09.005
Others include a substance called sibutramine, which has been banned in some countries
La tirzepatida , que se vende con la marca Mounjaro, y la semaglutida , que se vende con las marcas Ozempic y Wegovy, se administran una vez a la semana mediante inyecciones
Howell MJ et al
In Japan and Malaysia, you can even get your B12 shots in supermarkets